Ten-year survival after radical prostatectomy: specimen Gleason score is the predictor in organ-confined prostate cancer.
about
Assessment of apparent diffusion coefficient values as predictor of aggressiveness in peripheral zone prostate cancer: comparison with Gleason score.Evaluation of the normal-to-diseased apparent diffusion coefficient ratio as an indicator of prostate cancer aggressiveness.Technology insight: will systems pathology replace the pathologist?Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy.Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort.Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy.Characterising the castration-resistant prostate cancer population: a systematic review.Beta-2-microglobulin expression correlates with high-grade prostate cancer and specific defects in androgen signaling.Salvage radiotherapy for biochemical relapse after complete PSA response following radical prostatectomy: outcome and prognostic factors for patients who have never received hormonal therapyThe Utility of Diffusion Weighted Imaging (DWI) Using Apparent Diffusion Coefficient (ADC) Values in Discriminating Between Prostate Cancer and Normal Tissue.Characterization of a "low-risk" cohort of grade group 2 prostate cancer patients: Results from the Shared Equal Access Regional Cancer Hospital database.How localized is pathologically localized prostate cancer? The use of secondary circulating prostate cells as a marker of minimal residual disease and their association with patient outcome.
P2860
Q33711325-45465127-516E-4417-83B1-36F0AB3FC7D8Q35178690-13879905-53FD-4470-A9F0-2D894CD8D297Q36702749-719B0553-82D4-4365-ACEF-ACAF2300512FQ37016855-6B1A76A0-1F87-4E18-B196-E4BF583E09A6Q37616568-3F8C9BD3-31A7-48E9-80EB-9D5AE7D77B40Q37864722-CC1F8B17-9EF4-44FB-B7E9-11C959DBCA6CQ37945316-26549028-D3EE-46C8-A04D-381F975C7409Q39690365-5774E0B7-6227-4FE5-8898-CC1E93D98578Q42264405-D73B9F5F-7042-457B-8D7A-DACDD2E55395Q43056789-5C19BEAB-1C6B-4113-889E-467ED5A6E551Q43533918-57ABC63C-D035-422C-8937-98C18F1C989CQ46748035-565CD1A6-34ED-40B9-A0BC-72204C524DC2
P2860
Ten-year survival after radical prostatectomy: specimen Gleason score is the predictor in organ-confined prostate cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Ten-year survival after radica ...... rgan-confined prostate cancer.
@en
Ten-year survival after radica ...... rgan-confined prostate cancer.
@nl
type
label
Ten-year survival after radica ...... rgan-confined prostate cancer.
@en
Ten-year survival after radica ...... rgan-confined prostate cancer.
@nl
prefLabel
Ten-year survival after radica ...... rgan-confined prostate cancer.
@en
Ten-year survival after radica ...... rgan-confined prostate cancer.
@nl
P2093
P356
P1476
Ten-year survival after radica ...... rgan-confined prostate cancer.
@en
P2093
David P Wood
Fernando J Bianco
Isaac J Powell
J Edson Pontes
Julia W Souza
Michael L Cher
P304
P356
10.3816/CGC.2003.N.006
P577
2003-03-01T00:00:00Z